GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kabra Drugs Ltd (BOM:524322) » Definitions » Purchase Of Investment

Kabra Drugs (BOM:524322) Purchase Of Investment : ₹0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is Kabra Drugs Purchase Of Investment?

Kabra Drugs's purchase of investment for the three months ended in Dec. 2023 was ₹0.00 Mil. It means Kabra Drugs spent ₹0.00 Mil on purchasing investments. Kabra Drugs's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00 Mil.

Compared with last quarter (₹0.00 Mil in Sep. 2023 ), Kabra Drugs spent the same money on purchasing investments in Dec. 2023 (₹0.00 Mil).

Kabra Drugs Purchase Of Investment Historical Data

The historical data trend for Kabra Drugs's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kabra Drugs Purchase Of Investment Chart

Kabra Drugs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Kabra Drugs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kabra Drugs Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kabra Drugs Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Kabra Drugs's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Kabra Drugs (BOM:524322) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kabra Drugs Ltd (BOM:524322) » Definitions » Purchase Of Investment
Comparable Companies
BOM:524590 BOM:540108 BOM:539680 BOM:530207 BOM:524516 BOM:531686 BOM:524661 BOM:543444 BOM:531541 BOM:531762 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Swaminathan Street, No:3, 2nd Floor, West Mambalam, Chennai, TN, IND, 600033
Website
http://www.kabradrugs.com
Kabra Drugs Ltd is an India-based drug manufacturing company. It is engaged in the business of Permaculture manufacturing and trading in pharma related products. Geographically, all the company operations are carried out in India. It generates revenue from the sale of materials principally in India. The company plant for manufacturing the drugs is located in the Indian state of Madhya Pradesh. Its products include Cardiovascular Drugs, Anti-Infective Drugs, Oncology Drugs, Gastroenterologic Drugs, Hormonal Drugs, etc.

Kabra Drugs (BOM:524322) Headlines

No Headlines